Folic Acid-Modified Ibrutinib-Loaded Silk Fibroin Nanoparticles for Cancer Cell Therapy with Over-Expressed Folate Receptor

• मुख्य लेखकों: Marta G. Fuster (लेखक), Mercedes G. Montalbán (लेखक), Imane Moulefera (लेखक), Gloria Víllora (लेखक), David L. Kaplan (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2023-04-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

The anticancer drug ibrutinib (IB), also known as PCI-32765, is a compound that irreversibly inhibits Bruton's tyrosine kinase (BTK) and was initially developed as a treatment option for B-cell lineage neoplasms. Its action is not limited to B-cells, as it is expressed in all hematopoietic line...